331 related articles for article (PubMed ID: 27279342)
1. IgG/IgM antiphospholipid antibodies present in the classification criteria for the antiphospholipid syndrome: a critical review of their association with thrombosis.
Kelchtermans H; Pelkmans L; de Laat B; Devreese KM
J Thromb Haemost; 2016 Aug; 14(8):1530-48. PubMed ID: 27279342
[TBL] [Abstract][Full Text] [Related]
2. Identification of high thrombotic risk triple-positive antiphospholipid syndrome patients is dependent on anti-cardiolipin and anti-β2glycoprotein I antibody detection assays.
Chayoua W; Kelchtermans H; Moore GW; Musiał J; Wahl D; de Laat B; Devreese KMJ
J Thromb Haemost; 2018 Oct; 16(10):2016-2023. PubMed ID: 30079628
[TBL] [Abstract][Full Text] [Related]
3. Role of anti-domain 1-β2 glycoprotein I antibodies in the diagnosis and risk stratification of antiphospholipid syndrome.
De Craemer AS; Musial J; Devreese KM
J Thromb Haemost; 2016 Sep; 14(9):1779-87. PubMed ID: 27314634
[TBL] [Abstract][Full Text] [Related]
4. Measuring IgA Anti-β2-Glycoprotein I and IgG/IgA Anti-Domain I Antibodies Adds Value to Current Serological Assays for the Antiphospholipid Syndrome.
Pericleous C; Ferreira I; Borghi O; Pregnolato F; McDonnell T; Garza-Garcia A; Driscoll P; Pierangeli S; Isenberg D; Ioannou Y; Giles I; Meroni PL; Rahman A
PLoS One; 2016; 11(6):e0156407. PubMed ID: 27253369
[TBL] [Abstract][Full Text] [Related]
5. Clinical significance of anti-domain 1 β2-glycoprotein I antibodies in antiphospholipid syndrome.
Iwaniec T; Kaczor MP; Celińska-Löwenhoff M; Polański S; Musiał J
Thromb Res; 2017 May; 153():90-94. PubMed ID: 28363116
[TBL] [Abstract][Full Text] [Related]
6. The IgA Isotype of Anti-β2 Glycoprotein I Antibodies Recognizes Epitopes in Domains 3, 4, and 5 That Are Located in a Lateral Zone of the Molecule (L-Shaped).
Serrano M; Martinez-Flores JA; Norman GL; Naranjo L; Morales JM; Serrano A
Front Immunol; 2019; 10():1031. PubMed ID: 31134087
[No Abstract] [Full Text] [Related]
7. The (non-)sense of detecting anti-cardiolipin and anti-β2glycoprotein I IgM antibodies in the antiphospholipid syndrome.
Chayoua W; Kelchtermans H; Gris JC; Moore GW; Musiał J; Wahl D; de Groot PG; de Laat B; Devreese KMJ
J Thromb Haemost; 2020 Jan; 18(1):169-179. PubMed ID: 31519058
[TBL] [Abstract][Full Text] [Related]
8. Thrombotic risk assessment and analytical performance of the chemiluminescent analyzer IDS-iSYS for the detection of anti-cardiolipin and anti-beta 2 glycoprotein I autoantibodies.
Salma N; Julie L; Boutahar B; Sylvie LN; Eleonore B; Fabien LN; Elisabeth P; Sandrine JJ; Francis C; Sophie H; Yves R
Clin Immunol; 2018 Sep; 194():92-99. PubMed ID: 30017909
[TBL] [Abstract][Full Text] [Related]
9. Detection of anti-domain I antibodies by chemiluminescence enables the identification of high-risk antiphospholipid syndrome patients: A multicenter multiplatform study.
Yin D; Chayoua W; Kelchtermans H; de Groot PG; Moore GW; Gris JC; Zuily S; Musial J; de Laat B; Devreese KMJ
J Thromb Haemost; 2020 Feb; 18(2):463-478. PubMed ID: 31749277
[TBL] [Abstract][Full Text] [Related]
10. Both IgG and IgM anti-beta2 glycoprotein I antibodies assays are clinically useful to the antiphospholipid syndrome diagnosis.
Li R; Daguzan M; Vandermijnsbrugge F; Gyling M; Cantinieaux B
Acta Clin Belg; 2014 Dec; 69(6):433-8. PubMed ID: 25103595
[TBL] [Abstract][Full Text] [Related]
11. Anti-Phosphatidylserine/Prothrombin Antibodies at Two Points: Correlation With Lupus Anticoagulant and Thrombotic Risk.
Egri N; Bentow C; Rubio L; Norman GL; López-Sañudo S; Mahler M; Pérez-Isidro A; Cervera R; Viñas O; Espinosa G; Ruiz-Ortiz E
Front Immunol; 2021; 12():754469. PubMed ID: 34790198
[TBL] [Abstract][Full Text] [Related]
12. "Non-criteria" antiphospholipid antibodies add value to antiphospholipid syndrome diagnoses in a large Chinese cohort.
Liu T; Gu J; Wan L; Hu Q; Teng J; Liu H; Cheng X; Ye J; Su Y; Sun Y; Zhou J; Norman GL; Wang X; Yang C; Shi H
Arthritis Res Ther; 2020 Feb; 22(1):33. PubMed ID: 32085759
[TBL] [Abstract][Full Text] [Related]
13. APhL antibody ELISA as an alternative to anticardiolipin test for the diagnosis of antiphospholipid syndrome.
Suh-Lailam BB; Cromar A; Davis KW; Tebo AE
Int J Clin Exp Pathol; 2012; 5(3):210-5. PubMed ID: 22558475
[TBL] [Abstract][Full Text] [Related]
14. Interest of IgG and IgM antiprothrombin autoantibodies in the exploration of antiphospholipid syndrome: a 5-year retrospective study.
Bertin D; Beziane A; Resseguier N; Pelissier M; Morange PE; Mege JL; Bardin N
Rheumatology (Oxford); 2020 Jul; 59(7):1539-1544. PubMed ID: 31630203
[TBL] [Abstract][Full Text] [Related]
15. Antiphospholipid antibodies in patients with COVID-19: A relevant observation?
Devreese KMJ; Linskens EA; Benoit D; Peperstraete H
J Thromb Haemost; 2020 Sep; 18(9):2191-2201. PubMed ID: 32619328
[TBL] [Abstract][Full Text] [Related]
16. Immunoglobulin A anti-phospholipid antibodies in Swedish cases of systemic lupus erythematosus: associations with disease phenotypes, vascular events and damage accrual.
Frodlund M; Vikerfors A; Grosso G; Skogh T; Wetterö J; Elvin K; Gunnarsson I; Kastbom A; Dahlström Ö; Rönnelid J; Svenungsson E; Sjöwall C
Clin Exp Immunol; 2018 Oct; 194(1):27-38. PubMed ID: 30208508
[TBL] [Abstract][Full Text] [Related]
17. Clinical utility of laboratory tests used to identify antiphospholipid antibodies and to diagnose the antiphospholipid syndrome.
Galli M
Semin Thromb Hemost; 2008 Jun; 34(4):329-34. PubMed ID: 18814065
[TBL] [Abstract][Full Text] [Related]
18. Anti-Phospholipid Antibodies in COVID-19 Are Different From Those Detectable in the Anti-Phospholipid Syndrome.
Borghi MO; Beltagy A; Garrafa E; Curreli D; Cecchini G; Bodio C; Grossi C; Blengino S; Tincani A; Franceschini F; Andreoli L; Lazzaroni MG; Piantoni S; Masneri S; Crisafulli F; Brugnoni D; Muiesan ML; Salvetti M; Parati G; Torresani E; Mahler M; Heilbron F; Pregnolato F; Pengo M; Tedesco F; Pozzi N; Meroni PL
Front Immunol; 2020; 11():584241. PubMed ID: 33178218
[TBL] [Abstract][Full Text] [Related]
19. Laboratory evaluation of anti-phospholipid syndrome: a preliminary prospective study of phosphatidylserine/prothrombin antibodies in an at-risk patient cohort.
Heikal NM; Jaskowski TD; Malmberg E; Lakos G; Branch DW; Tebo AE
Clin Exp Immunol; 2015 May; 180(2):218-26. PubMed ID: 25522978
[TBL] [Abstract][Full Text] [Related]
20. Is There an Additional Value in Detecting Anticardiolipin and Anti-β2 glycoprotein I IgA Antibodies in the Antiphospholipid Syndrome?
Chayoua W; Yin DM; Kelchtermans H; Moore GW; Gris JC; Musiał J; Zuily S; Ten Cate H; de Laat B; Devreese KMJ
Thromb Haemost; 2020 Nov; 120(11):1557-1568. PubMed ID: 32696448
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
